RDW

RDW comes from a standard blood draw. It is reported on a complete blood count, and it measures how spread out your red blood cell sizes are. Most people never look at it.

That is a missed clue. A wider red-cell size spread has repeatedly predicted worse outcomes over the following years. It doesn't tell you what is wrong. It tells you something may be straining your body's ability to make or maintain normal red cells.

What the Number Reflects

RDW stands for red blood cell distribution width. It is a calculation an analyzer makes from the range of red-cell sizes in your blood sample. Your bone marrow makes red blood cells. When that process is steady, the cells are fairly uniform and RDW stays lower. When production is disturbed, cells of many sizes end up in circulation and the spread widens.

Several things can widen it. Iron, vitamin B12, or folate running short disrupts how red cells mature. Inflammation can slow production. Kidney disease and chronic illness can shorten red-cell survival. In 293 adults living in the community, a wider spread went along with red cells that were less able to squeeze through small vessels. That is a clue that RDW can track real changes in blood flow, not just a generic illness signal.

Heart Disease and Stroke

The strongest evidence is in cardiovascular disease. In a meta-analysis of 102,689 people with cardiovascular disease, each 1 percentage-point higher RDW was tied to about 12% higher risk of death and about 12% higher risk of a major cardiac event. That is a modest step-by-step effect. It mattered because it showed up across many groups.

NT-proBNP is a protein released when the heart is under stretch. In heart failure, RDW kept predicting outcomes even after researchers accounted for NT-proBNP and heart ultrasound. Adding RDW made prediction slightly sharper. Ischemic stroke is a stroke caused by a blocked vessel. Higher RDW has also been linked to worse outcomes after ischemic stroke and a higher chance of having one.

What this means for you: if you already have heart disease or are working to prevent it, a rising RDW is a reason to check nutrition, inflammation, kidney function, and the rest of your risk picture. It isn't a reason to change a heart plan by itself.

What Death Rates Reveal

Across the general population, the pattern is blunt. In a study of 3.16 million adults, people above the 99th percentile had a little more than twice the adjusted risk of dying compared with people in the middle half of the range. Among 4,273 hospitalized adults, 30-day death rates rose from about 1 in 70 in the lowest quarter to about 1 in 7 in the highest.

That gap is dramatic, but it has a reason. When researchers adjusted for inflammation, poor nutrition, and blood disease in hospitalized adults, much of the RDW signal disappeared. RDW is summarizing strain. It isn't creating it.

Anemia and Iron Deficiency

Before the prognosis research, RDW earned its keep in anemia workups. It can widen early in iron deficiency, sometimes before average cell size or hemoglobin has changed. That makes it a useful nudge to check iron. In a study of 190 pregnant women, RDW detected early iron deficiency better than hemoglobin or average cell size.

Thalassemia trait is inherited and often causes small red cells. Iron deficiency tends to create a wider spread, while thalassemia trait often creates small cells that are more uniform. That contrast is one reason RDW is read with MCV and the RBC count, not alone.

Kidney, Cancer, and Other Conditions

The reach is wide. In people with chronic kidney disease, higher RDW tracked faster loss of kidney function. Across cancer studies, a higher pretreatment RDW was linked to poorer survival, especially in colorectal, liver, and blood cancers in one meta-analysis. Higher readings also went with more severe COVID-19 and worse outcomes in sepsis. Sepsis is a life-threatening response to infection that can damage organs.

RDW doesn't diagnose any of these conditions on its own. In each case it tracks severity and prognosis after the illness is already defined.

Why a High Number Isn't a Diagnosis

How can a routine blood-count number predict heart attacks, kidney decline, and cancer death all at once? Because it is downstream of many problems. Low iron, low B12 or folate, inflammation, kidney disease, chronic infection, bleeding, and marrow stress can all make red cells come out less uniform. A high RDW should send you looking for a cause, not hand you one.

When Results Can Be Misleading

• Lab platform: RDW is reported two ways, RDW-CV and RDW-SD. Different analyzers calculate and report them differently, so compare results from the same lab's analyzer when you can.
• Age, sex, and pregnancy: RDW tends to rise with age, can differ by sex, and shifts during pregnancy. A borderline result needs that context.
• Recent iron treatment or transfusion: starting iron or receiving blood mixes cells of different sizes into your circulation and can push RDW up for weeks without any worsening of health.
• Methotrexate: this drug can raise RDW by changing red-cell maturation, even when the rise is more about the drug than a new disease signal.
• Uniformly small or large cells: a normal RDW only means the cells are similar in size. Longstanding thalassemia trait, iron deficiency, or B12/folate problems can still need workup if MCV or symptoms point that way.

Why One Reading Isn't Enough

A single value is a snapshot of strain at one moment, and because machines differ, one borderline reading is easy to over-read. The direction of change often carries more information than the level. In one heart-failure study, a rise after treatment predicted more events over the following year. That doesn't make RDW a treatment target. It makes the trend worth noticing.

What to Do With an Unexpected Result

If RDW is high and you feel well, don't panic. It is nonspecific by design. Read it against its companions: ferritin and iron studies, vitamin B12 and folate, hs-CRP, kidney function, and the rest of the blood count, especially hemoglobin and average cell size.

The pattern points the way. A wide spread with small cells and low ferritin points to iron deficiency. A wide spread with large cells points to B12 or folate. A wide spread with otherwise normal counts and a high inflammation marker points to something inflammatory. A persistent, unexplained elevation alongside anemia is worth a hematology opinion, while in someone with kidney or heart disease it is a signal to tighten management rather than a new problem in itself. If it is isolated and everything else is clean, a repeat test is more sensible than chasing it.